SNAQ Launches AI-Powered Glucose Prediction feature
SNAQ has introduced a groundbreaking AI-driven feature that predicts glucose responses before meals, revolutionizing diabetes care.
The new meal glucose prediction tool allows CGM users to anticipate their body’s reaction to food using a proprietary deep learning model and a unique digital twin approach. This innovation offers highly personalized insights for improved glucose control.
SNAQ also secured new funding led by the Diabetes Venture Fund at Serpentine Ventures, reinforcing investor confidence despite a tough market. CEO Aurelian Briner emphasized the company’s commitment to scaling innovations and transforming diabetes care. Looking ahead, SNAQ plans to introduce more AI-driven advancements to empower individuals in managing their health.
For more details, read the full press release or visit SNAQ’s website to learn more about their innovations in diabetes care.
More recent news
DT-Report 2026: Join now
The survey for the DT Report 2026 is now available – Take part and help shape the future of diabetes technology with...
Alva Innovation wins the DCB Open Innovation Challenge 2025
Bern, 6 November 2025 - The start-up Alva Innovations has won first place in the DCB Open Innovation Challenge. The...
A Day of Innovation: Swiss Diabetes Technology and Beyond
Join us on 5 November 2025 at sitem-insel, Bern for a day dedicated to inspiring ideas and new perspectives in perspectives in medtech, diabetes technology and beyond.



